Login

Alexandria, Boston Properties Team Up on Major Bay Area Biotech Campus

Venture Shows Surge in Top US Life Science Market, Boston, Isn't Slowing Demand in No. 2 Area Around San Francisco
Boston Properties is contributing three existing office buildings in South San Francisco, California, as part of an expanded new biotech campus it is planning with Alexandria Real Estate Equities. (CoStar)
Boston Properties is contributing three existing office buildings in South San Francisco, California, as part of an expanded new biotech campus it is planning with Alexandria Real Estate Equities. (CoStar)
CoStar News
January 30, 2020 | 3:47 AM

The biotech property boom in the nation's top life science market of Boston isn't slowing demand for the country's No. 2 spot, the San Francisco Bay Area, as Alexandria Real Estate Equities and developer Boston Properties embark on a 1.7 million-square-foot life science campus in South San Francisco.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In